← Every applicant
Solaris Pharma Corp FDA Approvals
8 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| NITROGLYCERINNew drugDec 18, 2025OINTMENT, INTRA-ANAL |
| TAZAROTENENew drugNov 24, 2025CREAM, TOPICAL |
| ESTRADIOLNew drugJul 12, 2024GEL, TRANSDERMAL |
| ESTRADIOLNew drugApr 22, 2024GEL, METERED, TRANSDERMAL |
| TAZAROTENENew drugMar 20, 2023GEL, TOPICAL |
| CLINDAMYCIN PHOSPHATE AND TRETINOINNew drugFeb 10, 2022GEL, TOPICAL |
| METRONIDAZOLENew drugOct 14, 2021GEL, VAGINAL |
| CLINDAMYCIN PHOSPHATENew drugAug 13, 2021GEL, TOPICAL |